Literature DB >> 28300203

Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.

Wei Song, Lin Tang, Yumei Xu, Jing Xu, Wenwen Zhang, Hui Xie, Shui Wang, Xiaoxiang Guan.   

Abstract

Entities:  

Year:  2017        PMID： 28300203      PMCID： PMC5353734          DOI： 10.1038/srep44346

Source DB:  PubMed          Journal:  Sci Rep        ISSN： 2045-2322            Impact factor:   4.379


× No keyword cloud information.
This Article contains an error in Figure 4A where the graphs were labelled incorrectly. The correct Figure 4A appears below as Figure 1.
Figure 1
  1 in total

1.  PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.

Authors:  Wei Song; Lin Tang; Yumei Xu; Jing Xu; Wenwen Zhang; Hui Xie; Shui Wang; Xiaoxiang Guan
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379
  1 in total
  2 in total

1.  Identifying the differentially expressed microRNAs in esophagus squamous cell carcinoma of Kazakh patients in Xinjiang.

Authors:  Liyun Cheng; Guijun Shi; Chunxiao Fang; Guanghua Li; Yong Zheng; Weigang Chen
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

2.  PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells.

Authors:  Hehui Fang; Juan Jin; Doudou Huang; Fang Yang; Xiaoxiang Guan
Journal:  Cancer Sci       Date:  2018-05-07       Impact factor: 6.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.